DRAFT FOR REVIEW BY APPOINTED CLINICAL SAFETY OFFICER — MUST BE REVIEWED, AMENDED AND SIGNED BY A GMC/NMC/HCPC-REGISTERED CLINICIAN WITH FORMAL DCB0129 CLINICAL SAFETY OFFICER TRAINING BEFORE USE.

CSO07 — Consolidated Hazard Log (All Five Solutions)

Document reference: BRITI-HAZLOG-001 Version: 0.9 (Draft for CSO review) Manufacturer: BritiAI Limited Applicable standard: DCB0129:2018 Status: Draft pending CSO sign-off


Scoring conventions

  • Severity: Catastrophic (Cat) / Major (Maj) / Considerable (Con) / Minor (Min) / Negligible (Neg).
  • Likelihood: Very High (VH) / High (H) / Medium (M) / Low (L) / Very Low (VL).
  • Risk score (illustrative numeric): Severity 5..1 × Likelihood 5..1 (max 25).
  • Acceptability: Unacceptable (U) / ALARP (A) / Acceptable (OK).
  • Owner: R&D = BritiAI R&D Lead; CSO = BritiAI Clinical Safety Officer; PROD = Product Lead; ENG = Engineering Lead; SUB-V = Votee AI; SUB-B = Beever AI; TRUST = deploying trust CSO (joint).

All residual scores assume implementation of the listed controls. Acceptability is recommended; final acceptability sits with the CSO.


1. Scribe-On-Site (SCR-01 to SCR-10)

IDHazardHazardous situationHarmInit SevInit LikeInit ScoreControls (Technical / Procedural / Training)Res SevRes LikeRes ScoreAcceptOwner
SCR-01Mis-transcription of drug nameWrong drug recorded in signed noteWrong prescription downstream; ADRMajM12T: drug-lexicon biased ASR, drug-name confidence highlight, formulary lookup overlay. P: mandatory clinician sign-off; side-by-side transcript vs draft. Tr: drug-name verification module.MajL8ACSO/PROD
SCR-02Mis-transcription of dose/unitsWrong dose recordedOver/under-dosingMajM12T: numeric span detection and highlighting; unit normalisation. P: clinician sign-off. Tr: numeric verification module.MajL8ACSO/PROD
SCR-03Omission of clinically significant contentSymptom/finding missing from draftMissed diagnosis / delayed careConM9T: coverage indicator; transcript-to-draft anchor map. P: mandatory review of full transcript. Tr: omission-awareness module.ConL6ACSO/PROD
SCR-04Fabrication (“hallucination”) in summaryContent in draft not in transcriptWrong record; downstream errorMajM12T: grounded summarisation with span citations; fabrication probe in CI; ungrounded suppression. P: clinician sign-off. Tr: hallucination-awareness.MajL8ACSO/ENG
SCR-05Unauthorised / non-consented recordingRecording without consentPrivacy breach; loss of trustConM9T: visible recording indicator; pre-record consent prompt. P: trust consent policy alignment. Tr: consent workflow.ConL6ATRUST/PROD
SCR-06Speaker mis-attributionClinician statement attributed to patientWrong record of patient reportConM9T: diarisation with confidence; role tagging. P: clinician review of attribution.ConL6ASUB-V/CSO
SCR-07Automation bias at sign-offClinician signs off plausible but flawed draftWrong record propagatesMajM12T: uncertainty surfacing; minimum-review-time prompt; required confirmation of safety-critical fields. P: edit-distance aggregate monitoring (not performance mgmt). Tr: human factors.MajL8ACSO
SCR-08Mis-routing of note to wrong patientNote saved against wrong recordWrong-patient documentationMajL8T: patient-record confirmation step with two patient identifiers. P: EHR-side checks. Tr: identification SOP.MajVL4OKENG/TRUST
SCR-09Loss/corruption of provenance auditInability to verify transcript/sourceInvestigation hamperedConL6T: immutable audit store; integrity hashing; replication. P: backup and DR.ConVL3OKENG
SCR-10Behavioural drift after model updateNew version degrades safety-critical accuracyIncreased SCR-01/02/04 riskMajM12T: pre-release evaluation; canary; rollback. P: CSO release sign-off. Tr: release notes.MajL8ACSO/ENG

2. WardFlow Copilot (WF-01 to WF-10)

IDHazardHazardous situationHarmInit SevInit LikeInit ScoreControls (T/P/Tr)Res SevRes LikeRes ScoreAcceptOwner
WF-01Erroneous TTO drug/dose/route/frequencyPharmacist passes incorrect TTOADR; readmissionMajM12T: formulary-bound drafting; dose range guards; duplicate/interaction flags; reconciliation panel. P: pharmacist verification. Tr: reconciliation SOP.MajL8ACSO/ENG
WF-02Omission of allergy/alert in summaryAllergy not surfaced post-dischargeADR; anaphylaxisCatL10T: mandatory allergy field with active confirmation; EHR allergy join. P: consultant sign-off. Tr: allergy module.CatVL5ACSO
WF-03Premature discharge promptingPatient flagged ready when criteria unmetUnsafe dischargeMajM12T: signal-only, no auto action; criteria checklist; coordinator dashboard. P: MDT decision retained. Tr: coordinator SOP.MajL8ACSO/PROD
WF-04Wrong-patient/wrong-admission attributionSummary built from wrong recordWrong documentation; wrong careMajL8T: patient/admission key checks; visible patient banner. P: clinician confirmation.MajVL4OKENG/TRUST
WF-05Stale EHR data at draft timeRecent obs not reflectedDecision on stale dataConM9T: data-recency indicator; refresh on open; minimum-freshness gate for safety-critical fields. P: clinician review.ConL6AENG
WF-06Agent tool misuse (out-of-scope action)Agent attempts action beyond allow-listUnauthorised system changeMajL8T: hard tool allow-list; deterministic guards; sandbox; deny-by-default. P: audit review.MajVL4OKENG/CSO
WF-07Mis-routing for sign-offSent to wrong consultant/delegateDelay; sign-off by inappropriate clinicianConM9T: rota-aware routing; delegation rules; escalation timer. P: ward sign-off SOP.ConL6APROD/TRUST
WF-08Automation bias in pharmacist sign-offPharmacist passes plausible flawed TTOADRMajM12T: change-highlighting vs inpatient chart; explicit confirm of high-risk drugs. P: two-person check for high-risk. Tr: pharmacist module.MajL8ACSO
WF-09Loss of audit trailCannot reconstruct agent stepsInvestigation hamperedConL6T: immutable log; integrity hashing. P: DR.ConVL3OKENG
WF-10Behavioural drift after model updateSummary/TTO behaviour degradesIncreased WF-01..03 riskMajM12T: pre-release eval; canary; rollback. P: CSO sign-off.MajL8ACSO/ENG

3. Atlas for Trusts (ATL-01 to ATL-10)

IDHazardHazardous situationHarmInit SevInit LikeInit ScoreControls (T/P/Tr)Res SevRes LikeRes ScoreAcceptOwner
ATL-01Stale/superseded guidance retrievedUser acts on outdated policyWrong process; potential clinical harmConM9T: supersession metadata; visual badges; suppression of superseded sources. P: knowledge-owner curation. Tr: induction banner.ConL6ATRUST/CSO
ATL-02Incorrect attribution (citation to source not containing claim)User trusts unfounded statementWrong actionConM9T: span-grounded composition; ungrounded suppression; citation validator. P: knowledge-owner audit.ConL6ASUB-B/ENG
ATL-03Misuse for direct clinical decision-makingUser queries patient-specific decisionInappropriate decision supportMajM12T: query classifier with nudge/redirect; banner. P: trust SOP. Tr: scope module.MajL8ACSO/PROD
ATL-04Partial retrieval missing critical caveatCaveat omitted from responseUnsafe actionConM9T: response-completeness checks; “consult source” banner. P: knowledge-owner review.ConL6AENG/CSO
ATL-05Role-access leakage (e.g. M&M to unauthorised role)Restricted content surfacedConfidentiality breachConL6T: role-based access at retrieval; audit. P: trust role mgmt.ConVL3OKENG/TRUST
ATL-06Misleading composition across sourcesAggregated answer distorts meaningWrong actionConM9T: single-source preference; conflict surfacing. P: knowledge-owner review.ConL6AENG
ATL-07Loss of version awareness in responseUser cannot tell effective dateWrong actionMinM6T: mandatory version + effective date in citation.MinL4OKENG
ATL-08Confidence overstatementResponse over-confident vs evidenceRelianceConM9T: calibrated hedging language; “consult source” banner.ConL6ACSO/ENG
ATL-09Prompt injection via ingested documentMalicious content alters behaviourMisleading outputConL6T: ingestion sanitisation; instruction isolation; provenance gating. P: knowledge-owner vetting.ConVL3OKENG/CSO
ATL-10Drift after model updateRetrieval/composition behaviour changesQuality degradationConM9T: eval suite incl regression set; canary; rollback. P: CSO sign-off.ConL6ACSO/ENG

4. MAGIC-NHS (MAG-01 to MAG-10)

IDHazardHazardous situationHarmInit SevInit LikeInit ScoreControls (T/P/Tr)Res SevRes LikeRes ScoreAcceptOwner
MAG-01Training data egressIdentifiable data leaves trust boundaryIG breach; patient harmMajL8T: no-egress architecture; egress firewall; redact telemetry. P: IG sign-off. Tr: engineer module.MajVL4OKENG/TRUST
MAG-02Insufficient de-identificationPII present in training corpusIG breachMajM12T: de-id pipeline; leakage scanner; held-out red-team set. P: trust IG sign-off.MajL8ASUB-V/TRUST
MAG-03Behavioural drift weakening refusalFine-tuned model answers out-of-scope queries unsafelyDownstream clinical harmMajM12T: refusal eval suite; gating thresholds. P: CSO + trust CSO promotion review.MajL8ACSO
MAG-04Fabrication regression post-fine-tuneModel fabricates clinical contentDownstream harm via SCR-04/ATL-02MajM12T: fabrication eval suite; gating thresholds. P: promotion review.MajL8ACSO
MAG-05Evaluation gapEval fails to detect regressionUnsafe artefact promotedMajM12T: layered eval (capability, safety, bias); periodic eval refresh. P: CSO review of eval scope.MajL8ACSO/ENG
MAG-06Inappropriate promotionArtefact promoted without joint sign-offUnsafe deploymentMajL8T: two-person rule; promotion record; signed model card. P: governance audit.MajVL4OKCSO/TRUST
MAG-07Reproducibility lossCannot reproduce run for investigationHampered incident responseConM9T: deterministic config; corpus + checkpoint hashing; logged seeds. P: artefact retention.ConL6AENG
MAG-08Bias amplificationDemographic bias amplified by fine-tuneDifferential harmMajM12T: bias probe suite; subgroup eval. P: promotion review.MajL8ACSO
MAG-09Supply-chain compromise of base model/depsTampered base/dependencyCompromised artefactMajL8T: signed artefacts; SBOM; provenance checks. P: vendor mgmt.MajVL4OKENG
MAG-10Model Card inaccuracyCard misrepresents limitationsUnsafe downstream useConM9T: card template auto-populated from eval; manual review. P: CSO sign-off of card.ConL6ACSO

5. Trial Concierge (TRI-01 to TRI-10)

IDHazardHazardous situationHarmInit SevInit LikeInit ScoreControls (T/P/Tr)Res SevRes LikeRes ScoreAcceptOwner
TRI-01False-positive eligibility flagPatient approached for ineligible trialDistress; inappropriate approach; protocol deviationConM9T: per-criterion evidence; conservative confidence threshold. P: mandatory clinician sign-off; PI oversight. Tr: GCP module.ConL6ACSO/PROD
TRI-02False-negative eligibility flagEligible patient missedLoss of access to investigational therapyConM9T: transparent criteria mapping; broaden-search option; periodic recall audit. P: PI oversight.ConL6ACSO/PROD
TRI-03Protocol Q&A misinterpretationClinician acts on incorrect Q&AProtocol deviation; patient harmMajM12T: citation-grounded responses; version pin; ungrounded suppression. P: protocol owner review. Tr: GCP module.MajL8ACSO/ENG
TRI-04Stale protocol version usedScreening against superseded protocolDeviation; harmMajM12T: version pin; supersession warnings; ingestion SLA. P: R&D office process.MajL8ATRUST/CSO
TRI-05EHR data drift / incompletenessScreening on incomplete dataWrong eligibilityConM9T: recency indicators; coverage report. P: clinician review.ConL6AENG
TRI-06Privacy escalation outside delegation logPatient data to unauthorised staffIG breachMajL8T: delegation-log RBAC; audit. P: R&D governance.MajVL4OKENG/TRUST
TRI-07Automation bias in clinician sign-offClinician approves flawed candidateInappropriate approachConM9T: per-criterion evidence required; explicit confirm. Tr: bias module.ConL6ACSO
TRI-08Wrong-patient evidence attributionEHR evidence mis-bound to patientWrong eligibility decisionMajL8T: identity binding checks; banner.MajVL4OKENG
TRI-09Cross-trial context contaminationCriteria from trial A influence trial BWrong decisionsConL6T: hard context isolation per trial; audit.ConVL3OKENG/CSO
TRI-10Behavioural drift after model updateScreening/Q&A degradeIncreased TRI-01..04 riskMajM12T: pre-release eval; canary; rollback. P: CSO sign-off.MajL8ACSO/ENG

Summary

  • Total hazards logged: 50 (10 per solution).
  • Initial risks predominantly Major × Medium or Considerable × Medium, reflecting the AI-mediated nature of the workflows.
  • After designed controls, no residual risk remains in the Unacceptable band; the majority sit at ALARP, with a minority at Acceptable.
  • ALARP entries require explicit CSO acceptance; rationale for acceptance is to be recorded in the CSCR sign-off.

Prepared by: BritiAI Quality and Clinical Safety function. To be reviewed, amended and signed by: Appointed Clinical Safety Officer.

CSO name: _________________________ Registration body and number: _________________________ Signature: _________________________ Date: _________________________